Alirocumab in patients with heterozygous familial hypercholesterolemia undergoing lipoprotein apheresis: Rationale and design of the ODYSSEY ESCAPE trial
Titel:
Alirocumab in patients with heterozygous familial hypercholesterolemia undergoing lipoprotein apheresis: Rationale and design of the ODYSSEY ESCAPE trial
Auteur:
Moriarty, Patrick M. Parhofer, Klaus G. Babirak, Stephan P. deGoma, Emil Duell, P. Barton Hohenstein, Bernd Ramlow, Wolfgang Simha, Vinaya Steinhagen-Thiessen, Elisabeth Thompson, Paul D. Vogt, Anja von Stritzky, Berndt Du, Yunling Manvelian, Garen